Efficacy and Safety of Biosimilar FYB201 Compared with Ranibizumab in Neovascular Age-Related Macular Degeneration

Authors:

Abstract
No abstract available
Funding Information
  • Bayer
  • Merck Sharp and Dohme United Kingdom
  • Genentech
  • Novartis
  • Roche
  • Biogen
  • Boehringer Ingelheim

This publication has 23 references indexed in Scilit: